Epstein-Barr Virus & MS: New Study Outcomes

Research Summary: Complete Epstein-Barr virus seropositivity in a large cohort of patients with early multiple sclerosis

A German study involving 901 people living with early multiple sclerosis (MS) has found that 100% of participants had antibodies against the Epstein-Barr virus (EBV). Performed by researchers at Charité – Universitätsmedizin Berlin, this research provides further compelling evidence that infection with EBV may play a role in multiple sclerosis.

In this video, MStranslate co-founder and chief science communicator, Brett Drummond, discusses the outcomes of this published paper in more detail and explains the potential implications of the findings.

If you have any questions for Brett, please either comment below or email them to him directly at
brett@mstranslate.com.au.

Anyone wanting to read the published paper discussed in this video, can do so by clicking here.

To read other articles that MStranslate has written in relation to EBV, please click here.